Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Editorial Volume 3 Issue 9

COVID-19 and Nervous Relation

Vijay Kumar*

Assistant Professor, Amity Institute of Neuropsychology and Neurosciences, Amity University, Noida, UP, India

*Corresponding Author: Vijay Kumar, Assistant Professor, Amity Institute of Neuropsychology and Neurosciences, Amity University, Noida, UP, India.

Received: July 03, 2020; Published: August 01, 2020


 The outbreak of novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has challenged the healthcare community around the world. As of July 3, 2020, there were over 10 million confirmed cases worldwide, with total deaths more than 5 lakhs (5% of total cases), and over 5 million recovered cases (53% recovery rate).



  1. Prasad K., et al. “Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective”. International Journal of Biological Macromolecules 163 (2020): 1-8.
  2. Ludlow M., et al. “Neurotropic virus infections as the cause of immediate and delayed neuropathology”. Acta Neuropathologica2 (2016): 159-184.
  3. Baig AM. “Neurological manifestations in COVID-19 caused by SARS-CoV-2”. CNS Neuroscience Therapy 5 (2020): 499-501.
  4. Baig AM., et al. “Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms”. ACS Chemical Neuroscience 11 (2020): 995-998.
  5. Zhou Z., et al. “Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms”. Journal of Neurology (2020).
  6. Wang D., et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China”. JAMA11 (2020): 1061-1069.
  7. Li Z., et al. “Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain”. Frontiers in Medicine (2020): 1-9.
  8. Zhao H., et al. “Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?” The Lancet Neurology5 (2020): 383-384.
  9. Gane SB., et al. “Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome”. Rhinology 10 (2020).
  10. Yeager A. “Lost smell and taste hint COVID-19 can target the Nervous system”. The Scientist (2020).
  11. Khatoon F., et al. “Neurological manifestations of COVID-19: Available evidences and a new paradigm to understand the complications”. Journal of Neurovirology (2020).


Citation: Vijay Kumar. “COVID-19 and Nervous Relation". Acta Scientific Neurology 3.9 (2020): 01-02.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US